Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Influence of Lymphocyte Dynamics and Immune Profile on Outcomes of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma

  • By

  • Mansi R. Shah

  • Aishee Bag

  • Asis Shrestha

  • Yetunde Ogunsesan

  • Anup Trikannad

  • Sruthi Vellanki

  • Sanjay Muttineni

  • Hira Cheema

  • Syed Naqvi

  • Sasya Dronavalli

  • Samer Al Hadidi

  • Sharmilan Thanendrarjan

  • Maurizio Zangari

  • Frits van Rhee

  • Aniko Szabo

  • Rajshekar Chakraborty

  • Meera Mohan

  • Carolina Schinke

  • August 22, 2026

Share

Original Source(s)

Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma

  • by Mansi R. Shah, Aishee Bag, Asis Shrestha, Yetunde Ogunsesan, Anup Trikannad, Sruthi Vellanki, Sanjay Muttineni, Hira Cheema, Syed Naqvi, Sasya Dronavalli, Samer Al Hadidi, Sharmilan Thanendrarjan, Maurizio Zangari, Frits van Rhee, Aniko Szabo, Rajshekar Chakraborty, Meera Mohan, Carolina Schinke

  • August 22, 2026

Related Content

Correction: Prognostic significance of inflammation-based markers in nasopharyngeal carcinoma: a systematic review and meta-analysis

Correction: Identification of patients at risk for poor survival among those with normal skeletal muscle mass: a multicenter retrospective validation study in gastric cancer

Graded and threshold effects of body mass index on perioperative outcomes after pancreaticoduodenectomy: a meta-analysis incorporating an institutional cohort